Document is current
Any future updates will be listed below
-
Authors
Crespo, Grace Velez https://orcid.org/0000-0001-5082-3804
Ortiz, Jescelica
O’Farrill, Eliud Hernández
Vlaar, Cornelis P.
Inyushin, Mikhail
Kucheryavykh, Yuriy
Kucheryavykh, Lilia
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (1SC1GM12269)
National Institute of General Medical Sciences (P20GM103475)
National Institute of General Medical Sciences (SC3GM116713)
National Institute of General Medical Sciences (SC3GM143983)
- License Information
-
More Information
Article History
Received: 4 January 2023
Accepted: 5 June 2023
First Online: 14 June 2023
Declarations
:
: All animal studies were conducted under protocol #042-2018-30-01-IBC-PHA, approved by the UCC Institutional Animal Care and Use Committee, in accordance with the NIH Guideline for the Care and Use of Laboratory Animals.
: Not applicable.
: CPV and EHO are inventors of subject compounds, described in patent US10,729,689, assigned to the University of Puerto Rico. GVC, J.O, MI, LK, YK declare not conflict of interest.
